Global Antidiabetic SGLT-2 Inhibitor Sales Market Report 2021

August 2016 | 110 pages | ID: G64F6C7A516EN
QYResearch

Abstracts

This report studies sales (consumption) of Antidiabetic SGLT-2 Inhibitor in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Sanofi
• Johnson & Johnson
• Bristol-Myers Squibb
• AstraZeneca
• Boehringer Ingelheim
• GlaxoSmithKline
• Pfizer
• Takeda Pharmaceuticals
• Eli Lilly
• Merck & Co.
• Novo Nordisk

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antidiabetic SGLT-2 Inhibitor in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type 1
• Type 2
• Type 3

Split by applications, this report focuses on sales, market share and growth rate of Antidiabetic SGLT-2 Inhibitor in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

1 ANTIDIABETIC SGLT-2 INHIBITOR OVERVIEW

1.1 Product Overview and Scope of Antidiabetic SGLT-2 Inhibitor
1.2 Classification of Antidiabetic SGLT-2 Inhibitor
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Applications of Antidiabetic SGLT-2 Inhibitor
1.4 Antidiabetic SGLT-2 Inhibitor Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Antidiabetic SGLT-2 Inhibitor (2011-2021)
  1.5.1 Global Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
  1.5.2 Global Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
  1.5.3 Global Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)

2 GLOBAL ANTIDIABETIC SGLT-2 INHIBITOR COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Antidiabetic SGLT-2 Inhibitor Market Competition by Manufacturers
  2.1.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Antidiabetic SGLT-2 Inhibitor (Volume and Value) by Type
  2.2.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type (2011-2021)
  2.2.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Market Share by Type (2011-2021)
2.3 Global Antidiabetic SGLT-2 Inhibitor (Volume and Value) by Regions
  2.3.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Market Share by Regions (2011-2021)
2.4 Global Antidiabetic SGLT-2 Inhibitor (Volume) by Application

3 NORTH AMERICA ANTIDIABETIC SGLT-2 INHIBITOR (VOLUME, VALUE AND SALES PRICE

3.1 North America Antidiabetic SGLT-2 Inhibitor Sales and Value (2011-2021)
  3.1.1 North America Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
  3.1.2 North America Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
  3.1.3 North America Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
3.2 North America Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Manufacturers
3.3 North America Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type
3.4 North America Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Applications

4 CHINA ANTIDIABETIC SGLT-2 INHIBITOR (VOLUME, VALUE AND SALES PRICE

4.1 China Antidiabetic SGLT-2 Inhibitor Sales and Value (2011-2021)
  4.1.1 China Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
  4.1.2 China Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
  4.1.3 China Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
4.2 China Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Manufacturers
4.3 China Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type
4.4 China Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Applications

5 EUROPE ANTIDIABETIC SGLT-2 INHIBITOR (VOLUME, VALUE AND SALES PRICE

5.1 Europe Antidiabetic SGLT-2 Inhibitor Sales and Value (2011-2021)
  5.1.1 Europe Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
  5.1.2 Europe Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
5.2 Europe Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Manufacturers
5.3 Europe Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type
5.4 Europe Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Applications

6 JAPAN ANTIDIABETIC SGLT-2 INHIBITOR (VOLUME, VALUE AND SALES PRICE

6.1 Japan Antidiabetic SGLT-2 Inhibitor Sales and Value (2011-2021)
  6.1.1 Japan Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
  6.1.2 Japan Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
6.2 Japan Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Manufacturers
6.3 Japan Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type
6.4 Japan Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Applications

7 SOUTHEAST ASIA ANTIDIABETIC SGLT-2 INHIBITOR (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales and Value (2011-2021)
  7.1.1 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
7.2 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Manufacturers
7.3 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type
7.4 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Applications

8 INDIA ANTIDIABETIC SGLT-2 INHIBITOR (VOLUME, VALUE AND SALES PRICE

8.1 India Antidiabetic SGLT-2 Inhibitor Sales and Value (2011-2021)
  8.1.1 India Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
  8.1.2 India Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
  8.1.3 India Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
8.2 India Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Manufacturers
8.3 India Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type
8.4 India Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Applications

9 GLOBAL ANTIDIABETIC SGLT-2 INHIBITOR MANUFACTURERS ANALYSIS

9.1 Sanofi
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology
    9.1.2.1 Type
    9.1.2.2 Type
  9.1.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Company One (2015 and 2016)
9.2 Johnson & Johnson
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology
    9.2.2.1 Type
    9.2.2.2 Type
  9.2.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Company One (2015 and 2016)
9.3 Bristol-Myers Squibb
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology
    9.3.2.1 Type
    9.3.2.2 Type
  9.3.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Company One (2015 and 2016)
9.4 AstraZeneca
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology
    9.4.2.1 Type
    9.4.2.2 Type
  9.4.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Boehringer Ingelheim
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology
    9.5.2.1 Type
    9.5.2.2 Type
  9.5.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Company One (2015 and 2016)
9.6 GlaxoSmithKline
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology
    9.6.2.1 Type
    9.6.2.2 Type
  9.6.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Company One (2015 and 2016)
9.7 Pfizer
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology
    9.7.2.1 Type
    9.7.2.2 Type
  9.7.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Company One (2015 and 2016)
9.8 Takeda Pharmaceuticals
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology
    9.8.2.1 Type
    9.8.2.2 Type
  9.8.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Company One (2015 and 2016)
9.9 Eli Lilly
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology
    9.9.2.1 Type
    9.9.2.2 Type
  9.9.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Company One (2015 and 2016)
9.10 Merck & Co.
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Antidiabetic SGLT-2 Inhibitor Product Type and Technology
    9.10.2.1 Type
    9.10.2.2 Type
  9.10.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Company One (2015 and 2016)
9.11 Novo Nordisk

10 ANTIDIABETIC SGLT-2 INHIBITOR TECHNOLOGY AND DEVELOPMENT TREND

10.1 Antidiabetic SGLT-2 Inhibitor Technology Analysis
10.2 Antidiabetic SGLT-2 Inhibitor Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic SGLT-2 Inhibitor
Table Classification of Antidiabetic SGLT-2 Inhibitor
Figure Global Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Types in 2015
Table Applications of Antidiabetic SGLT-2 Inhibitor
Figure Global Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Applications in 2015
Figure North America Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure China Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure Europe Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure Japan Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure India Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table Global Antidiabetic SGLT-2 Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antidiabetic SGLT-2 Inhibitor Sales Share by Manufacturers
Figure 2016 Antidiabetic SGLT-2 Inhibitor Sales Share by Manufacturers
Table Global Antidiabetic SGLT-2 Inhibitor Revenue by Manufacturers (2015 and 2016)
Table Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers
Table 2016 Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers
Table Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales Share by Type (2011-2021)
Figure Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Type (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Type (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Revenue and Market Share by Type (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Antidiabetic SGLT-2 Inhibitor by Type (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Revenue Growth Rate by Type (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Regions (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales Share by Regions (2011-2021)
Figure Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Regions (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Regions (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Revenue and Market Share by Regions (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Antidiabetic SGLT-2 Inhibitor by Regions (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Revenue Growth Rate by Regions (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Application (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales Share by Application (2011-2021)
Figure Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Application (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Application (2011-2021)
Figure North America Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
Figure North America Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure North America Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
Table North America Antidiabetic SGLT-2 Inhibitor Sales by Manufacturers (2015 and 2016)
Table North America Antidiabetic SGLT-2 Inhibitor Market Share by Manufacturers (2015 and 2016)
Table North America Antidiabetic SGLT-2 Inhibitor Sales by Type (2015 and 2016)
Table North America Antidiabetic SGLT-2 Inhibitor Market Share by Type (2015 and 2016)
Table North America Antidiabetic SGLT-2 Inhibitor Sales by Applications (2015 and 2016)
Table North America Antidiabetic SGLT-2 Inhibitor Market Share by Applications (2015 and 2016)
Figure Europe Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
Figure Europe Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure Europe Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
Table Europe Antidiabetic SGLT-2 Inhibitor Sales by Manufacturers (2015 and 2016)
Table Europe Antidiabetic SGLT-2 Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Europe Antidiabetic SGLT-2 Inhibitor Sales by Type (2015 and 2016)
Table Europe Antidiabetic SGLT-2 Inhibitor Market Share by Type (2015 and 2016)
Table Europe Antidiabetic SGLT-2 Inhibitor Sales by Applications (2015 and 2016)
Table Europe Antidiabetic SGLT-2 Inhibitor Market Share by Applications (2015 and 2016)
Figure China Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
Figure China Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure China Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
Table China Antidiabetic SGLT-2 Inhibitor Sales by Manufacturers (2015 and 2016)
Table China Antidiabetic SGLT-2 Inhibitor Market Share by Manufacturers (2015 and 2016)
Table China Antidiabetic SGLT-2 Inhibitor Sales by Type (2015 and 2016)
Table China Antidiabetic SGLT-2 Inhibitor Market Share by Type (2015 and 2016)
Table China Antidiabetic SGLT-2 Inhibitor Sales by Applications (2015 and 2016)
Table China Antidiabetic SGLT-2 Inhibitor Market Share by Applications (2015 and 2016)
Figure Japan Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
Figure Japan Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure Japan Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
Table Japan Antidiabetic SGLT-2 Inhibitor Sales by Manufacturers (2015 and 2016)
Table Japan Antidiabetic SGLT-2 Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Japan Antidiabetic SGLT-2 Inhibitor Sales by Type (2015 and 2016)
Table Japan Antidiabetic SGLT-2 Inhibitor Market Share by Type (2015 and 2016)
Table Japan Antidiabetic SGLT-2 Inhibitor Sales by Applications (2015 and 2016)
Table Japan Antidiabetic SGLT-2 Inhibitor Market Share by Applications (2015 and 2016)
Figure India Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
Figure India Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure India Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
Table India Antidiabetic SGLT-2 Inhibitor Sales by Manufacturers (2015 and 2016)
Table India Antidiabetic SGLT-2 Inhibitor Market Share by Manufacturers (2015 and 2016)
Table India Antidiabetic SGLT-2 Inhibitor Sales by Type (2015 and 2016)
Table India Antidiabetic SGLT-2 Inhibitor Market Share by Type (2015 and 2016)
Table India Antidiabetic SGLT-2 Inhibitor Sales by Applications (2015 and 2016)
Table India Antidiabetic SGLT-2 Inhibitor Market Share by Applications (2015 and 2016)
Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2011-2021)
Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales by Type (2015 and 2016)
Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Market Share by Type (2015 and 2016)
Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales by Applications (2015 and 2016)
Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Market Share by Applications (2015 and 2016)
Table Sanofi Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table AstraZeneca Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Boehringer Ingelheim Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Pfizer Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Takeda Pharmaceuticals Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)
Table Eli Lilly Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Eli Lilly (2015 and 2016)
Table Merck & Co. Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Merck & Co. (2015 and 2016)
Table Novo Nordisk Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Novo Nordisk (2015 and 2016)